跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EYEZIRGAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
EYEZIRGAN
Authorized
STANDARD
EYEZIRGAN
LABORATOIRES THEA
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2d80d9330b10513e
Company
LABORATOIRES THEA
Type
Standard
Approval Details
Approval Id
2d80d9330b10513e
Drug Approval Canada Name
EYEZIRGAN
Product Name
EYEZIRGAN
Status
Marketed
Status Date
2023-09-26
Original Market Date
2023-09-26
Din
02530546
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:04.20
Atc Original
S01AD09 GANCICLOVIR
Atc Name
s 01 ad 09
Aig Number
0128037004
Company Name
LABORATOIRES THEA
Company Address
12 Rue Louis Bleriot, Clermont-Ferrand, Cedex 2, France, 63017
Company Detail Path
/organization/laboratoires-thea
Company Information
Pharmaceutical Company Name
LABORATOIRES THEA
Country Name
France
Province Name
auvergne rhone alpes,country_fr
City Name
clermont-ferrand,auvergne rhone alpes,country_fr
Address
ZI DU BREZET
Website
http://www.laboratoires-thea.com/
Active Ingredients
GANCICLOVIR
0.15 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2d80d9330b10513e
Type
Standard
Back to Health Canada Approvals